Neurotrack nabs $90K for its tech that predicts the onset of Alzheimer’s (exclusive)
The $90,000 boost from angel investors is the first outside capital for the company with a diagnostic test for Alzheimer's disease.
The $90,000 boost from angel investors is the first outside capital for the company with a diagnostic test for Alzheimer's disease.
The goal for the multiyear partnership is to make genetic analysis a routine part of patient care.
Diagnostics, sensors, genomics and more world-class health tech might be the newest crop of innovations by and for China and its rapidly aging population.
People have health care, and now clouds have "cloud care." The only difference? Cloud care is free.
TODAY’S HEADLINES:
Stent maker IDev Tech raises $25M (VentureWire)
Xytis gets $15M for brain-injury drugs (VentureWire)
Diagnostic maker Iris Biotech plans to go public, launch breast-cancer test (Edgar)
RiverVest Venture Partners raises $75M life-science fund (release)
Concentric Medical names Maria
…
TODAY’S HEADLINES:
AGI Dermatics takes in $5M for skincare products (release)
Myconostica raises £3.9 for fungal diagnostics (GenomeWeb)
Germany’s Noxxon gets €1M grant for aptamer drugs (release)
AGI Dermatics takes in $5M for skincare products – Freeport, N.Y.-based AGI Dermatics, …
TODAY’S HEADLINES:
OptiMedica takes in $16M for eye-treatment lasers (release)
Genome analyzer BioNanomatrix raises $5M (release)
Heart diagnostic startup Aviir gets another $1.5M (VBLS exclusive)
Pharmaca, integrative-pharmacy chain, draws $20M (release)
LifeWatch, cardiac-monitoring device maker, withdraws IPO (IPOhome)
Jerry DeVries,
…
TODAY’S HEADLINES:
Paris-based Stentys takes $18M for “bifurcated” stents (release)
Blood analyzer IntelliDx raises $22M (PDF release)
Cancer-test biotech Calderome changes name to VeraCyte (VentureWire)
Predictive Biosciences names Peter Klemm as CEO (release)
Paris-based Stentys takes $18M for “bifurcated” stents …
TODAY’S HEADLINES:
Luminous Medical raises $24M for automated glucose monitoring (release)
Alimera Sciences gets $30M for eye-disease drug (release)
Vaccine maker LigoCyte draws $28M (release)
Heartbeat tracker CardioNet trims IPO, aims for listing today (IPOhome)
Axial Biotech takes in $6M
…
TODAY’S HEADLINES
Cantimer takes in $2M for dehydration diagnostics (VentureWire)
Recodagen launches, takes aim at cancer (release)
Juniper Diagnostics spins out of ChemSensing (VentureWire)
Cantimer takes in $2M for dehydration diagnostics –The mystery of Menlo Park, Calif.-based Cantimer has …
TODAY’S HEADLINES:
Affinergy gets $3M in grants for biological “linkers” (release)
Specialty pharma EUSA raises $50M, spends $23M for public biotech Cytogen (release)
Calderome takes in $12M for cancer diagnostics (peHUB)
Pulse Health raises $2M for handheld free-radical device (release)
…
TODAY’S HEADLINES:
Allegro pulls in $4M for lung-cancer molecular diagnostics (release)
Ocular bandage developer I-Therapeutix raises $6M (Mass High Tech)
NanoBio gets last of $30M for skin-infection drugs (release)
Cayenne Medical raises $15M for sports medicine (release)
Aridis Pharma seeks
…
(UPDATED: See below.)
Another one bites the dust.
The saga of Precision Therapeutics, a Pittsburgh biotech developing what struck me last August as a particularly crude type of cancer-chemotherapy diagnostic, continues apace. In a tersely worded press release, the …
TODAY’S HEADLINES:
Precision Thera merger with “blank check” Oracle Healthcare collapses (release)
Sleep Solutions takes in $21M for sleep-apnea diagnostics (release)
Trevena takes in $24M for drugs targeting G-proteins (release)
“Specialty biotech” PanGenetics gets €23M for antibody drugs (release) Cancer-drug
…
TODAY’S HEADLINES:
InfraReDx takes $17M for arterial-plaque detection (VentureWire)
Cancer-drug developer Serenex sells out to Pfizer for undisclosed sum (release)
Life-sciences fund Longitude Capital raises $95M (VentureWire)
Hospital consultant Intercede Health names Gray Miller as CEO (release)
InfraReDx takes $17M …
(NOTE: This item originally appeared in today’s daily briefing. It’s been expanded and rewritten here.)
DNA-based diagnostics face a fundamental, though hardly insuperable, obstacle: When you’re looking for a rare mutation or other identifying sequence of DNA “letters” (technically …
TODAY’S HEADLINES:
Adnavance pulls in C$3.7M for molecular diagnostics, names new CEO (release)
“Personalized medicine” co. Proprius sells to Cypress Bio for up to $75M (release)
Vaccinex raises $25M in wake of GSK deal for antibody drugs (VentureWire)
Cianna Medical
…
TODAY’S HEADLINES:
Microsoft launches $3M fund to support online health-improvement tools (release)
Clarus Ventures raises $660M life-sciences fund (release)
Iverson Genetics raises $1.1M for blood-clotting tests, seeks $9.3M more (VentureWire)
Upstart Ventures aims for $30M fund to seed Utah life-science
…
TODAY’S HEADLINES:
Compact ultrasound maker Zonare Medical raises $30M (VentureWire)
TherOx raises $30M for hypersaturated-oxygen devices (peHUB)
Accumetrics, antiplatelet-drug diagnostic maker, raises $29M (release)
Population Genetics takes in £3.8M for massively parallel genome studies (GenomeWeb)
“Brain fitness” trainer Dakim raises
…
TODAY’S HEADLINES:
Molecular-diagnostics maker Atlas Genetics gets £2.1M (MS Word release)
One-man shop Paloma Pharma takes in $5M for eye, cancer drugs (VentureWire)
Israel’s Optimata receives $1.5M for simulations to rescue failed drugs (release)
Centrose raises $1.3M for sugar-modified drugs
…